194 related articles for article (PubMed ID: 31002579)
21. Major hepatectomy and right hemicolectomy at the time of primary cytoreductive surgery for advanced ovarian cancer: report of a case.
Chalkiadakis GE; Lasithiotakis KG; Petrakis I; Kourousis C; Georgoulias V
Int J Gynecol Cancer; 2005; 15(6):1115-9. PubMed ID: 16343191
[TBL] [Abstract][Full Text] [Related]
22. Transitional cell carcinoma of the ovary.
Lin CH; Liu FS; Ho ES
Taiwan J Obstet Gynecol; 2006 Sep; 45(3):268-71. PubMed ID: 17175479
[TBL] [Abstract][Full Text] [Related]
23. The prognostic relevance of node metastases in optimally cytoreduced advanced ovarian cancer.
Bachmann C; Brucker SY; Kraemer B; Rothmund R; Staebler A; Fend F; Wallwiener D; Grischke EM
J Cancer Res Clin Oncol; 2015 Aug; 141(8):1475-80. PubMed ID: 25739827
[TBL] [Abstract][Full Text] [Related]
24. [Primary cytoreductive surgery of advanced ovarian cancer with special reference to the significance of bowel resection].
Sato K; Horiguchi M; Kimura M; So E; Kojima T; Tamuna M; Shima Y; Numaguchi M; Uno K; Maru H
Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1070-7. PubMed ID: 2730012
[TBL] [Abstract][Full Text] [Related]
25. Which Patients With Cervical Squamous Cell Carcinoma Might Benefit From Neoadjuvant Chemotherapy?
Mahmoud O; Einstein MH
J Clin Oncol; 2018 Jun; 36(16):1543-1547. PubMed ID: 29668367
[TBL] [Abstract][Full Text] [Related]
26. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
27. Transitional cell carcinoma of the ovary: a rare case and review of literature.
Tazi EM; Lalya I; Tazi MF; Ahellal Y; M'rabti H; Errihani H
World J Surg Oncol; 2010 Nov; 8():98. PubMed ID: 21073751
[TBL] [Abstract][Full Text] [Related]
28. Outcomes of patients with advanced stage ovarian cancer with intestinal metastasis.
Kebapcı E; Gülseren V; Tuğmen C; Gökçü M; Solmaz U; Sert İ; Kocaer M; Özer M; Ölmez M; Sancı M
Ginekol Pol; 2017; 88(10):537-542. PubMed ID: 29192414
[TBL] [Abstract][Full Text] [Related]
29. [Synchronous primary cancers of the endometrium and ovary: review of 43 cases].
Ma SK; Zhang HT; Sun YC; Wu LY
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):690-4. PubMed ID: 19173912
[TBL] [Abstract][Full Text] [Related]
30. Ovarian low-grade serous carcinoma involving the cervix mimicking a cervical primary.
Malpica A; Deavers MT
Int J Gynecol Pathol; 2011 Nov; 30(6):613-9. PubMed ID: 21979600
[TBL] [Abstract][Full Text] [Related]
31. Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.
Mourton SM; Temple LK; Abu-Rustum NR; Gemignani ML; Sonoda Y; Bochner BH; Barakat RR; Chi DS
Gynecol Oncol; 2005 Dec; 99(3):608-14. PubMed ID: 16153697
[TBL] [Abstract][Full Text] [Related]
32. Breast Reconstruction With Postmastectomy Radiation: Choices and Tradeoffs.
Poppe MM; Agarwal JP
J Clin Oncol; 2017 Aug; 35(22):2467-2470. PubMed ID: 28481705
[TBL] [Abstract][Full Text] [Related]
33. Hyperamylasemia may indicate the presence of ovarian carcinoma: A case report.
Guo S; Lv H; Yan L; Rong F
Medicine (Baltimore); 2018 Dec; 97(49):e13520. PubMed ID: 30544453
[TBL] [Abstract][Full Text] [Related]
34. Extended left upper quadrant resection during primary cytoreductive surgery for Stage IV ovarian cancer.
Sawyer BT; LaFargue CJ; Bristow RE
Gynecol Oncol; 2016 Aug; 142(2):378. PubMed ID: 27264212
[TBL] [Abstract][Full Text] [Related]
35. Chronic administration of single weekly paclitaxel in heavily pretreated ovarian cancer patients.
Yamamoto K; Oogi S; Inoue H; Kudoh K; Kita T; Kikuchi Y
Curr Med Chem; 2004 Feb; 11(4):425-8. PubMed ID: 14965223
[TBL] [Abstract][Full Text] [Related]
36. [Retained ovarian remnant carcinoma: a case report].
Le Bouëdec G; Bailly C; De Lapasse C; Gimbergues P; Dauplat J
J Gynecol Obstet Biol Reprod (Paris); 2006 Dec; 35(8 Pt 1):829-33. PubMed ID: 17151542
[TBL] [Abstract][Full Text] [Related]
37. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings.
Kim HJ; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):343-7. PubMed ID: 25286788
[TBL] [Abstract][Full Text] [Related]
38. Is Estradiol Monitoring Necessary in Women Receiving Ovarian Suppression for Breast Cancer?
Papakonstantinou A; Foukakis T; Rodriguez-Wallberg KA; Bergh J
J Clin Oncol; 2016 May; 34(14):1573-9. PubMed ID: 26951320
[TBL] [Abstract][Full Text] [Related]
39. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
Veras E; Deavers MT; Silva EG; Malpica A
Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
[TBL] [Abstract][Full Text] [Related]
40. Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer.
Berretta R; Capozzi VA; Sozzi G; Volpi L; Ceni V; Melpignano M; Giordano G; Marchesi F; Monica M; Di Serio M; Riccò M; Ceccaroni M
Arch Gynecol Obstet; 2018 Apr; 297(4):997-1004. PubMed ID: 29380107
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
